Efficacy of AXERT (almotriptan malate) in the acute treatment of migraine: a pilot study of the potential impact of preventive therapy with TOPAMAX (topiramate).

Trial Profile

Efficacy of AXERT (almotriptan malate) in the acute treatment of migraine: a pilot study of the potential impact of preventive therapy with TOPAMAX (topiramate).

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Mar 2010

At a glance

  • Drugs Almotriptan; Topiramate
  • Indications Migraine
  • Focus Pharmacodynamics
  • Most Recent Events

    • 30 Mar 2010 Actual patient number (406) added as reported by ClinicalTrials.gov.
    • 30 Mar 2010 Actual end date added to 1 Jun 2007 as reported by ClinicalTrials.gov.
    • 19 Oct 2007 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top